Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients.
BMC Public Health. 2021 Jul 16;21(1):1404. doi: 10.1186/s12889-021-11427-y.
BMC Public Health. 2021.
PMID: 34271884
Free PMC article.
Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis.
Mulder C, Rupert S, Setiawan E, Mambetova E, Edo P, Sugiharto J, Useni S, Malhotra S, Cook-Scalise S, Pambudi I, Kadyrov A, Lawanson A, van den Hof S, Gebhard A, Juneja S, Sohn H.
Mulder C, et al. Among authors: cook scalise s.
BMJ Glob Health. 2022 Jan;7(1):e007182. doi: 10.1136/bmjgh-2021-007182.
BMJ Glob Health. 2022.
PMID: 34992077
Free PMC article.
Item in Clipboard
Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations.
Kendall EA, Malhotra S, Cook-Scalise S, Denkinger CM, Dowdy DW.
Kendall EA, et al. Among authors: cook scalise s.
BMC Infect Dis. 2019 Sep 9;19(1):794. doi: 10.1186/s12879-019-4429-x.
BMC Infect Dis. 2019.
PMID: 31500572
Free PMC article.
Item in Clipboard
Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines.
Gomez GB, Siapka M, Conradie F, Ndjeka N, Garfin AMC, Lomtadze N, Avaliani Z, Kiria N, Malhotra S, Cook-Scalise S, Juneja S, Everitt D, Spigelman M, Vassall A.
Gomez GB, et al. Among authors: cook scalise s.
BMJ Open. 2021 Dec 3;11(12):e051521. doi: 10.1136/bmjopen-2021-051521.
BMJ Open. 2021.
PMID: 34862287
Free PMC article.
Item in Clipboard
Clinical Impact of Rapid Drug Susceptibility Testing to Accompany Fluoroquinolone-Containing Universal Tuberculosis Regimens: A Markov Model.
Kendall EA, Malhotra S, Cook-Scalise S, Dowdy DW, Denkinger CM.
Kendall EA, et al. Among authors: cook scalise s.
Clin Infect Dis. 2020 Dec 31;71(11):2889-2896. doi: 10.1093/cid/ciz1179.
Clin Infect Dis. 2020.
PMID: 31813958
Free PMC article.
Item in Clipboard
Cite
Cite